世界のプレミックスインスリン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Premix Insulin Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4756
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、プレミックスインスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プレミックスヒトインスリン、プレミックスインスリンアナログ）、用途別市場規模（家庭、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・プレミックスインスリンの市場動向
・企業の競争状況、市場シェア
・プレミックスインスリンの種類別市場規模と予測2016-2027（プレミックスヒトインスリン、プレミックスインスリンアナログ）
・プレミックスインスリンの用途別市場規模と予測2016-2027（家庭、医療機関、その他）
・プレミックスインスリンの北米市場規模2016-2027（アメリカ、カナダ）
・プレミックスインスリンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・プレミックスインスリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・プレミックスインスリンの中南米市場規模2016-2027（メキシコ、ブラジル）
・プレミックスインスリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novo Nordisk、Eli Lilly、Teva、Pfizer、Sanofi）
・結論

Premix Insulin is a combination of two insulins mixed together: one insulin that is short-acting or fast-acting, plus one insulin that is intermediate-acting. Premix Insulin can reduce postprandial blood glucose and reduce fasting blood glucose. According to the variety, premixed insulin can be divided into two categories: premixed human insulin and premixed insulin analogues.

Market Analysis and Insights: Global Premix Insulin Market
The global Premix Insulin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premix Insulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premix Insulin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premix Insulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premix Insulin market.

Global Premix Insulin Scope and Market Size
Premix Insulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premix Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Premixed Human Insulin
Premixed Insulin Analogues

Segment by Application
Home Use
Medical Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Eli Lilly
Teva
Pfizer
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premix Insulin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Premixed Human Insulin
1.2.3 Premixed Insulin Analogues
1.3 Market by Application
1.3.1 Global Premix Insulin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Premix Insulin Market Perspective (2016-2027)
2.2 Premix Insulin Growth Trends by Regions
2.2.1 Premix Insulin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Premix Insulin Historic Market Share by Regions (2016-2021)
2.2.3 Premix Insulin Forecasted Market Size by Regions (2022-2027)
2.3 Premix Insulin Industry Dynamic
2.3.1 Premix Insulin Market Trends
2.3.2 Premix Insulin Market Drivers
2.3.3 Premix Insulin Market Challenges
2.3.4 Premix Insulin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Premix Insulin Players by Revenue
3.1.1 Global Top Premix Insulin Players by Revenue (2016-2021)
3.1.2 Global Premix Insulin Revenue Market Share by Players (2016-2021)
3.2 Global Premix Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Premix Insulin Revenue
3.4 Global Premix Insulin Market Concentration Ratio
3.4.1 Global Premix Insulin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premix Insulin Revenue in 2020
3.5 Premix Insulin Key Players Head office and Area Served
3.6 Key Players Premix Insulin Product Solution and Service
3.7 Date of Enter into Premix Insulin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Premix Insulin Breakdown Data by Type
4.1 Global Premix Insulin Historic Market Size by Type (2016-2021)
4.2 Global Premix Insulin Forecasted Market Size by Type (2022-2027)

5 Premix Insulin Breakdown Data by Application
5.1 Global Premix Insulin Historic Market Size by Application (2016-2021)
5.2 Global Premix Insulin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Premix Insulin Market Size (2016-2027)
6.2 North America Premix Insulin Market Size by Type
6.2.1 North America Premix Insulin Market Size by Type (2016-2021)
6.2.2 North America Premix Insulin Market Size by Type (2022-2027)
6.2.3 North America Premix Insulin Market Size by Type (2016-2027)
6.3 North America Premix Insulin Market Size by Application
6.3.1 North America Premix Insulin Market Size by Application (2016-2021)
6.3.2 North America Premix Insulin Market Size by Application (2022-2027)
6.3.3 North America Premix Insulin Market Size by Application (2016-2027)
6.4 North America Premix Insulin Market Size by Country
6.4.1 North America Premix Insulin Market Size by Country (2016-2021)
6.4.2 North America Premix Insulin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Premix Insulin Market Size (2016-2027)
7.2 Europe Premix Insulin Market Size by Type
7.2.1 Europe Premix Insulin Market Size by Type (2016-2021)
7.2.2 Europe Premix Insulin Market Size by Type (2022-2027)
7.2.3 Europe Premix Insulin Market Size by Type (2016-2027)
7.3 Europe Premix Insulin Market Size by Application
7.3.1 Europe Premix Insulin Market Size by Application (2016-2021)
7.3.2 Europe Premix Insulin Market Size by Application (2022-2027)
7.3.3 Europe Premix Insulin Market Size by Application (2016-2027)
7.4 Europe Premix Insulin Market Size by Country
7.4.1 Europe Premix Insulin Market Size by Country (2016-2021)
7.4.2 Europe Premix Insulin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Premix Insulin Market Size (2016-2027)
8.2 Asia-Pacific Premix Insulin Market Size by Type
8.2.1 Asia-Pacific Premix Insulin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Premix Insulin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Premix Insulin Market Size by Type (2016-2027)
8.3 Asia-Pacific Premix Insulin Market Size by Application
8.3.1 Asia-Pacific Premix Insulin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Premix Insulin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Premix Insulin Market Size by Application (2016-2027)
8.4 Asia-Pacific Premix Insulin Market Size by Region
8.4.1 Asia-Pacific Premix Insulin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Premix Insulin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Premix Insulin Market Size (2016-2027)
9.2 Latin America Premix Insulin Market Size by Type
9.2.1 Latin America Premix Insulin Market Size by Type (2016-2021)
9.2.2 Latin America Premix Insulin Market Size by Type (2022-2027)
9.2.3 Latin America Premix Insulin Market Size by Type (2016-2027)
9.3 Latin America Premix Insulin Market Size by Application
9.3.1 Latin America Premix Insulin Market Size by Application (2016-2021)
9.3.2 Latin America Premix Insulin Market Size by Application (2022-2027)
9.3.3 Latin America Premix Insulin Market Size by Application (2016-2027)
9.4 Latin America Premix Insulin Market Size by Country
9.4.1 Latin America Premix Insulin Market Size by Country (2016-2021)
9.4.2 Latin America Premix Insulin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Premix Insulin Market Size (2016-2027)
10.2 Middle East & Africa Premix Insulin Market Size by Type
10.2.1 Middle East & Africa Premix Insulin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Premix Insulin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Premix Insulin Market Size by Type (2016-2027)
10.3 Middle East & Africa Premix Insulin Market Size by Application
10.3.1 Middle East & Africa Premix Insulin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Premix Insulin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Premix Insulin Market Size by Application (2016-2027)
10.4 Middle East & Africa Premix Insulin Market Size by Country
10.4.1 Middle East & Africa Premix Insulin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Premix Insulin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Premix Insulin Introduction
11.1.4 Novo Nordisk Revenue in Premix Insulin Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Premix Insulin Introduction
11.2.4 Eli Lilly Revenue in Premix Insulin Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Premix Insulin Introduction
11.3.4 Teva Revenue in Premix Insulin Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Premix Insulin Introduction
11.4.4 Pfizer Revenue in Premix Insulin Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Premix Insulin Introduction
11.5.4 Sanofi Revenue in Premix Insulin Business (2016-2021)
11.5.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Premix Insulin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Premixed Human Insulin
Table 3. Key Players of Premixed Insulin Analogues
Table 4. Global Premix Insulin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Premix Insulin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Premix Insulin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Premix Insulin Market Share by Regions (2016-2021)
Table 8. Global Premix Insulin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Premix Insulin Market Share by Regions (2022-2027)
Table 10. Premix Insulin Market Trends
Table 11. Premix Insulin Market Drivers
Table 12. Premix Insulin Market Challenges
Table 13. Premix Insulin Market Restraints
Table 14. Global Premix Insulin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Premix Insulin Market Share by Players (2016-2021)
Table 16. Global Top Premix Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premix Insulin as of 2020)
Table 17. Ranking of Global Top Premix Insulin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Premix Insulin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Premix Insulin Product Solution and Service
Table 21. Date of Enter into Premix Insulin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Premix Insulin Revenue Market Share by Type (2016-2021)
Table 25. Global Premix Insulin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Premix Insulin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Premix Insulin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Premix Insulin Revenue Market Share by Application (2016-2021)
Table 29. Global Premix Insulin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Premix Insulin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Premix Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Premix Insulin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Premix Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Premix Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Premix Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Premix Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Premix Insulin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Premix Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Premix Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Premix Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Premix Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Premix Insulin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Premix Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Premix Insulin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Premix Insulin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Premix Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Premix Insulin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Premix Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Premix Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Premix Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Premix Insulin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Premix Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Premix Insulin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Premix Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Premix Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Premix Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novo Nordisk Company Details
Table 62. Novo Nordisk Business Overview
Table 63. Novo Nordisk Premix Insulin Product
Table 64. Novo Nordisk Revenue in Premix Insulin Business (2016-2021) & (US$ Million)
Table 65. Novo Nordisk Recent Development
Table 66. Eli Lilly Company Details
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Premix Insulin Product
Table 69. Eli Lilly Revenue in Premix Insulin Business (2016-2021) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Premix Insulin Product
Table 74. Teva Revenue in Premix Insulin Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Premix Insulin Product
Table 79. Pfizer Revenue in Premix Insulin Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Premix Insulin Product
Table 84. Sanofi Revenue in Premix Insulin Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premix Insulin Market Share by Type: 2020 VS 2027
Figure 2. Premixed Human Insulin Features
Figure 3. Premixed Insulin Analogues Features
Figure 4. Global Premix Insulin Market Share by Application: 2020 VS 2027
Figure 5. Home Use Case Studies
Figure 6. Medical Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. Premix Insulin Report Years Considered
Figure 9. Global Premix Insulin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Premix Insulin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Premix Insulin Market Share by Regions: 2020 VS 2027
Figure 12. Global Premix Insulin Market Share by Regions (2022-2027)
Figure 13. Global Premix Insulin Market Share by Players in 2020
Figure 14. Global Top Premix Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premix Insulin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Premix Insulin Revenue in 2020
Figure 16. Global Premix Insulin Revenue Market Share by Type (2016-2021)
Figure 17. Global Premix Insulin Revenue Market Share by Type (2022-2027)
Figure 18. North America Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Premix Insulin Market Share by Type (2016-2027)
Figure 20. North America Premix Insulin Market Share by Application (2016-2027)
Figure 21. North America Premix Insulin Market Share by Country (2016-2027)
Figure 22. United States Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Premix Insulin Market Share by Type (2016-2027)
Figure 26. Europe Premix Insulin Market Share by Application (2016-2027)
Figure 27. Europe Premix Insulin Market Share by Country (2016-2027)
Figure 28. Germany Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Premix Insulin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Premix Insulin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Premix Insulin Market Share by Region (2016-2027)
Figure 38. China Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Premix Insulin Market Share by Type (2016-2027)
Figure 46. Latin America Premix Insulin Market Share by Application (2016-2027)
Figure 47. Latin America Premix Insulin Market Share by Country (2016-2027)
Figure 48. Mexico Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Premix Insulin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Premix Insulin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Premix Insulin Market Share by Country (2016-2027)
Figure 54. Turkey Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Premix Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novo Nordisk Revenue Growth Rate in Premix Insulin Business (2016-2021)
Figure 58. Eli Lilly Revenue Growth Rate in Premix Insulin Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Premix Insulin Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Premix Insulin Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Premix Insulin Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の動物用インスリン市場規模・現状・予測（2021年-2027年）

Global Animal Insulin Market Size, Status and Forecast 2021-2027
QFJ1-3811 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、動物用インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブタインスリン、ウシインスリン）、用途別市場規模（人間、動物）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Non Insulin Anti diabetes Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4583 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、インスリン非依存型糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のインスリンペン＆ペンニードル市場規模・現状・予測（2021年-2027年）

Global Insulin Pen and Pen Needle Market Size, Status and Forecast 2021-2027
QFJ1-5214 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、インスリンペン＆ペンニードルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インスリンペン、ペンニードル）、用途別市場規模（家庭用、医療機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年）

Global Long Acting Insulins Market Size, Status and Forecast 2021-2027
QFJ1-4437 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、長時間作用型インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インスリングラルギン、インスリンデテミル、インスリンデグルデク、長時間作用型動物インスリン）、用途別市場規模（家庭用、医療機関、そ...

世界のワンステップELISA市場規模・現状・予測（2021年-2027年）

Global One-step ELISA Market Size, Status and Forecast 2021-2027
QFJ1-4608 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ワンステップELISAの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IgG、アルブミン、TNFα、IL-6、フィブリノーゲン、インスリン、リゾチーム、その他）、用途別市場規模（製薬・バイオテクノロジ...

世界の1型糖尿病治療市場規模・現状・予測（2021年-2027年）

Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4993 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、1型糖尿病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（速効型インスリン、速効型インスリン、その他）、用途別市場規模（病院・診療所、学術研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のチルミコシン＆誘導体市場規模・現状・予測（2021年-2027年）

Global Tilmicosin and Derivatives Market Size, Status and Forecast 2021-2027
QFJ1-4958 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、チルミコシン＆誘導体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（チルミコシン、チルミコシンプレミックス）、用途別市場規模（動物用医薬品、動物飼料添加物）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界の動物用インスリン市場規模・現状・予測（2021年-2027年） Animal insulin is derived from cows and pigs. Animal insulin was the first type of insulin to be administered to humans to control diabetes. Until the 1980s, animal insulin was the only treatment for insulin dependent diabetes. Currently, the use of animal insulin has been largely replaced by human …
世界のインスリンペン＆ペンニードル市場規模・現状・予測（2021年-2027年） An insulin pen is a convenient way to give yourself an insulin shot or injection, Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. Market Analysis and Insights: Global Insulin Pen and Pen Needle Market The global Insulin Pen and Pen Needle mark…
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…
インスリングラルギンのグローバル市場2021 Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a…
インスリンペン用針のグローバル市場2021 Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are …